← FDA Drug Approvals (Drugs@FDA)

DEFERASIROX

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ZYDUS PHARMS · Approved 2020-06-15

Drug application

FDA Application #

ANDA211383

Application type

Abbreviated New Drug Application (Generic)

Brand name

DEFERASIROX

Generic name

DEFERASIROX

Active ingredients

DEFERASIROX

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

ZYDUS PHARMS

Manufacturer

Zydus Pharmaceuticals USA Inc.

First approval

2020-06-15

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown